The post Ethereum ETFs Add $5.04M in Daily Inflows as Total Assets Hit $18.88B appeared on BitcoinEthereumNews.com. TLDR The total daily net inflow for all EthereumThe post Ethereum ETFs Add $5.04M in Daily Inflows as Total Assets Hit $18.88B appeared on BitcoinEthereumNews.com. TLDR The total daily net inflow for all Ethereum

Ethereum ETFs Add $5.04M in Daily Inflows as Total Assets Hit $18.88B

2026/01/13 19:41
Okuma süresi: 3 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.

TLDR

  • The total daily net inflow for all Ethereum ETFs was $5.04 million, with a cumulative total of $12.44 billion.
  • ETHA faced a $79.88M outflow, while ETHE recorded a daily inflow of $50.67M on January 12.
  • ETH ETF, TETH, and QETH saw over $39M in combined daily inflows, with ETH leading at $29.28M.
  • FETH, ETHW, EZET, and ETHV remained stable, with no daily inflows or outflows recorded.
  • Total net assets across Ethereum ETFs stood at $18.88 billion, representing 5.04% of Ethereum’s market cap.

According to a recent SoSoValue update as of January 12, the total daily net inflow across all Ethereum ETFs was $5.04 million, with a cumulative total of $12.44 billion. The total value traded across all Ethereum ETFs amounted to $940.66 million. The total net assets across these products were $18.88 billion, representing 5.04% of Ethereum’s market cap.

$79.88M Exits ETHA While ETHE Records $50.67M Inflow

A deep dive on individual Ethereum ETFs reveals that ETHA recorded a daily net outflow of $79.88 million, a 1-day ETH outflow of 25.69K. Its cumulative net inflow is $12.64 billion, and its net assets stand at $10.83 billion. The Ethereum ETF gained 1.08% in price, trading $554.53 million with 23.59 million shares.

Source: SoSoValue (Ethereum ETFs)

ETHE posted a daily net inflow of $50.67 million and a 1-day ETH inflow of 16.30K. Its cumulative net inflow is -$5.09 billion, with net assets at $2.77 billion. The ETF rose 1.04% in price and traded $109.38 million with 4.30 million shares.

ETH ETF, TETH, and QETH Record Over $39M in Combined Daily Inflows

ETH recorded a daily net inflow of $29.28 million, with 9.42K ETH added to the fund. The ETF’s cumulative net inflow reached $1.53 billion, and it reported $2.29 billion in net assets. The fund closed at $29.31, gained 1.07%, and traded $151.42 million in value.

TETH reported a daily net inflow of $4.97 million with a 1.60K ETH inflow. It has a cumulative net inflow of $29.84 million and net assets totaling $62.50 million. The ETF gained 0.22% in price and traded $39.28 million.

QETH had a daily net inflow of $5.55 million and a cumulative inflow of $26.96 million. It holds $26.96 million in net assets and gained 1.08% in price, trading $713.52 million with 346.44K shares.

 FETH, ETHW, EZET, and ETHV Ethereum ETFs Remain Stable

FETH reported no daily inflows or outflows. Its cumulative net inflow is $2.65 billion, and it holds $2.31 billion in net assets. The ETF saw a 0.95% price gain and traded $88.95 million with 2.87 million shares.

ETHW had no reported daily inflow or outflow, with net assets totaling $387.60 million. The ETF saw a 1.00% daily price gain and traded $22.74 million, with 1.02 million shares.

EZET saw no inflows or outflows, with a cumulative net inflow of $170.37 million. Its net assets stand at $162.61 million, and the Ethereum ETF gained 1.00% in price, trading $5.45 million.

ETHV reported no daily inflow, maintaining a stable position during the trading session. Its cumulative net inflow remained at $170.37 million, with $162.61 million in net assets under management. The ETF gained 1.14%, closing at $45.40, and saw $5.45 million in trading activity.

The post Ethereum ETFs Add $5.04M in Daily Inflows as Total Assets Hit $18.88B appeared first on Blockonomi.

Source: https://blockonomi.com/ethereum-etfs-add-5-04m-in-daily-inflows-as-total-assets-hit-18-88b/

Piyasa Fırsatı
Ethereum Logosu
Ethereum Fiyatı(ETH)
$1,985.87
$1,985.87$1,985.87
-1.23%
USD
Ethereum (ETH) Canlı Fiyat Grafiği

SPACEX(PRE) Launchpad

SPACEX(PRE) LaunchpadSPACEX(PRE) Launchpad

Register for a chance to win a free lucky draw

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26
Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin shorts risk $2.5 billion liquidation at $72K: Are bears in danger?

Bitcoin is poised for a reversal if ETF demand returns or a ceasefire occurs, potentially crushing short sellers in a massive price squeeze.
Paylaş
Coin Telegraph2026/04/04 19:58
Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Robotics Automation Prototyping: Engineering Kinetic Agility into End-Effectors

Inertia is the invisible tax on modern industrial throughput. Every millisecond a robotic arm spends decelerating, or waiting for high-frequency vibrations to settle
Paylaş
Techbullion2026/04/02 18:25

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage